# US 2009/0269802 A1 · Alpha 1,4-galactosyltransferase and dna encoding thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2009/0269802 A1
- Document ID: US20090269802A1
- Status: Published application
- Kind: A1
- Application number: 11/852,609
- Filed: 2007-09-10
- Published: 2009-10-29
- Earliest claimed: 2000-02-14
- Assignees: Seikagaku Corporation
- Inventors: Yoshinao KOJIMA; Satoshi Fukumoto; Keiko Furukawa; Tetsuya Okajima; Koichi Furukawa
- Web page: https://patentgrep.com/patent/US20090269802A1

## CPC

- C12N 9/1051: {Hexosyltransferases (2.4.1)}
- C12P 19/58: having an oxygen atom of the saccharide radical directly bound through only acyclic carbon atoms to a non-saccharide heterocyclic ring, e.g. bleomycin, phleomycin
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}

## Abstract

The object of the present invention is to provide α1,4-galactosyltransferase to transfer a galactose residue to C4 position of galactose residue of lactosylceramide or galactosylceramide, and DNA coding for the enzyme. What is provided includes the following polypeptides (a) and (b), and DNAs encoding thereof: (a) a polypeptide consisting of an amino acid sequence represented by the amino acid Nos. 46-353 in SEQ ID NO: 2; or (b) a polypeptide which comprises an amino acid sequence including substitution, deletion, insertion or transposition of one or few amino acids in the amino acid sequence of (a) and which has an enzymatic activity to transfer a galactose residue from a galactose donor to C4 position of galactose residue of lactosylceramide or galactosylceramide which serves as an acceptor.

## Claims

### Claim 1

A polypeptide of (a) or (b) below:
(a) a polypeptide consisting of an amino acid sequence represented by the amino acid Nos. 46-353 in SEQ ID NO: 2; or
(b) a polypeptide which comprises an amino acid sequence including substitution, deletion, insertion or transposition of one or few amino acids in the amino acid sequence of (a) and which has an enzymatic activity to transfer a galactose residue from a galactose donor to C4 position of galactose residue of lactosylceramide or galactosylceramide which serves as an acceptor.

### Claim 2

A polypeptide of (a′) or (b′) below:
(a′) a polypeptide consisting of an amino acid sequence represented by the amino acid Nos. 20-353 in SEQ ID NO:2; or
(b′) a polypeptide which comprises an amino acid sequence including substitution, deletion, insertion or transposition of one or few amino acids in the amino acid sequence of (a′) and which has an enzymatic activity to transfer a galactose residue from a galactose donor to C4 position of galactose residue of lactosylceramide or galactosylceramide which serves as an acceptor.

### Claim 3

A polypeptide of (a″) or (b″) below:
(a″) a polypeptide consisting of an amino acid sequence represented by SEQ ID NO:2; or
(b″) a polypeptide which comprises an amino acid sequence including substitution, deletion, insertion or transposition of one or few amino acids in the amino acid sequence of (a″) and which has an enzymatic activity to transfer a galactose residue from a galactose donor to C4 position of galactose residue of lactosylceramide or galactosylceramide which serves as an acceptor.

### Claim 4 (depends on 1, 2, 3)

A DNA encoding the polypeptide according to any one of claims 1 to 3.

### Claim 5 (depends on 4)

The DNA according to claim 4 represented by (a) or (b) below:
(a) a DNA comprising a nucleotide sequence represented by nucleotide Nos. 269 to 1192 in SEQ ID NO:1; or
(b) a DNA hybridizable with a DNA comprising a nucleotide sequence represented by SEQ ID NO:1, a nucleotide sequence complimentary to SEQ ID NO:1, or a part of those sequences, under a stringent condition.

### Claim 6 (depends on 5)

The DNA according to claim 5 encoding a polypeptide having an enzymatic activity to transfer a galactose residue from a galactose donor to C4 position of galactose residue of lactosylceramide or galactosylceramide which serves as an acceptor.

### Claim 7 (depends on 4, 5, 6)

A recombination vector containing the DNA as described in any one of claims 4 to 6.

### Claim 8 (depends on 4, 5, 6, 7)

A transformed cell obtained by transfecting a host cell with the DNA according to any one of claims 4 to 6, or the recombination vector according to claim 7.

### Claim 9 (depends on 1, 2, 3, 8)

A method for producing the polypeptide according to any one of claims 1 to 3, comprising the steps of:
expressing the polypeptide according to claims 1 to 3 by culturing the transformed cell according to claim 8 in a medium suitable for expressing the polypeptide; and
recovering said polypeptide from the medium and/or a cell extract of the cultured transformed cell.

### Claim 10 (depends on 1, 2, 3, 8)

A method for producing Gb3/CD77, comprising the steps of:
exposing the polypeptide according to any one of claims 1 to 3, or a cultured product of the transformed cell according to claim 8, to lactosylceramide, to cause thereby enzymatic reaction; and
recovering Gb3/CD77.

### Claim 11 (depends on 1, 2, 3, 8)

A method for producing a glycolipid represented by the following formula (I), comprising the steps of:
exposing the polypeptide according to any one of claims 1 to 3, or a cultured product of the transformed cell according to claim 8, to galactosylceramide, to cause thereby enzymatic reaction; and
recovering the glycolipid represented by the following formula (I):
Galα1→4Gal-Cer (1)
wherein Gal represents a galactose residue, Cer represents a ceramide residue and α1→4 represents an α1-4 glycosidic linkage.
